GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (ASX:ATX) » Definitions » Common Stock

Amplia Therapeutics (ASX:ATX) Common Stock : A$151.53 Mil (As of Sep. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Amplia Therapeutics Common Stock?

Amplia Therapeutics's quarterly common stock stayed the same from Sep. 2022 (A$151.53 Mil) to Mar. 2023 (A$151.53 Mil) and stayed the same from Mar. 2023 (A$151.53 Mil) to Sep. 2023 (A$151.53 Mil).

Amplia Therapeutics's annual common stock increased from Mar. 2021 (A$136.55 Mil) to Mar. 2022 (A$151.51 Mil) and increased from Mar. 2022 (A$151.51 Mil) to Mar. 2023 (A$151.53 Mil).


Amplia Therapeutics Common Stock Historical Data

The historical data trend for Amplia Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Common Stock Chart

Amplia Therapeutics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 132.90 136.55 151.51 151.53 151.53

Amplia Therapeutics Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 151.51 151.53 151.53 151.53 151.53

Amplia Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Amplia Therapeutics (ASX:ATX) Business Description

Traded in Other Exchanges
Address
350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics (ASX:ATX) Headlines

No Headlines